JPS59187778A - 微生物を培養するための培地 - Google Patents
微生物を培養するための培地Info
- Publication number
- JPS59187778A JPS59187778A JP58244546A JP24454683A JPS59187778A JP S59187778 A JPS59187778 A JP S59187778A JP 58244546 A JP58244546 A JP 58244546A JP 24454683 A JP24454683 A JP 24454683A JP S59187778 A JPS59187778 A JP S59187778A
- Authority
- JP
- Japan
- Prior art keywords
- medium
- culture medium
- bordetella
- culture
- cyclodextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 17
- 239000001963 growth medium Substances 0.000 title claims abstract description 14
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 12
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002609 medium Substances 0.000 claims description 37
- 238000012258 culturing Methods 0.000 claims description 10
- 239000011574 phosphorus Substances 0.000 claims description 9
- 229910052698 phosphorus Inorganic materials 0.000 claims description 9
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 abstract description 18
- 241000588807 Bordetella Species 0.000 abstract description 11
- 241000588832 Bordetella pertussis Species 0.000 abstract description 11
- 229920001817 Agar Polymers 0.000 abstract description 5
- 239000008272 agar Substances 0.000 abstract description 5
- 239000007788 liquid Substances 0.000 abstract description 4
- 241000588779 Bordetella bronchiseptica Species 0.000 abstract description 3
- 241000588780 Bordetella parapertussis Species 0.000 abstract description 3
- 239000001888 Peptone Substances 0.000 abstract description 2
- 108010080698 Peptones Proteins 0.000 abstract description 2
- 235000019319 peptone Nutrition 0.000 abstract description 2
- 239000007787 solid Substances 0.000 abstract description 2
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 12
- 238000000034 method Methods 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 6
- 239000013543 active substance Substances 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 201000005702 Pertussis Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 4
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000003463 adsorbent Substances 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 239000002054 inoculum Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 239000001116 FEMA 4028 Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 2
- 229960004853 betadex Drugs 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- -1 cyclodextrin saccharide Chemical class 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940052491 bordetella pertussis Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000006203 ethylation Effects 0.000 description 1
- 238000006200 ethylation reaction Methods 0.000 description 1
- HOXINJBQVZWYGZ-UHFFFAOYSA-N fenbutatin oxide Chemical compound C=1C=CC=CC=1C(C)(C)C[Sn](O[Sn](CC(C)(C)C=1C=CC=CC=1)(CC(C)(C)C=1C=CC=CC=1)CC(C)(C)C=1C=CC=CC=1)(CC(C)(C)C=1C=CC=CC=1)CC(C)(C)C1=CC=CC=C1 HOXINJBQVZWYGZ-UHFFFAOYSA-N 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 1
- 229940025294 hemin Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 206010024378 leukocytosis Diseases 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 229940066827 pertussis vaccine Drugs 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 229940124856 vaccine component Drugs 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58244546A JPS59187778A (ja) | 1983-12-27 | 1983-12-27 | 微生物を培養するための培地 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58244546A JPS59187778A (ja) | 1983-12-27 | 1983-12-27 | 微生物を培養するための培地 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16347881A Division JPS5918989B2 (ja) | 1981-10-15 | 1981-10-15 | 生物学的活性物質の製法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59187778A true JPS59187778A (ja) | 1984-10-24 |
| JPS6144470B2 JPS6144470B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1986-10-02 |
Family
ID=17120304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58244546A Granted JPS59187778A (ja) | 1983-12-27 | 1983-12-27 | 微生物を培養するための培地 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59187778A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60152502A (ja) * | 1983-12-17 | 1985-08-10 | コンゾルテイウム・フユール・エレクトロケミツシエ・インヅストリー・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | β‐シクロデキストリンの水溶性エーテルおよびその製法 |
| WO2017195888A1 (ja) * | 2016-05-12 | 2017-11-16 | 国立大学法人 東京大学 | 固体培地での微生物の増殖能を増強する方法 |
| JP2021090403A (ja) * | 2019-12-12 | 2021-06-17 | 栄研化学株式会社 | レジオネラ属菌培養用の透明培地 |
-
1983
- 1983-12-27 JP JP58244546A patent/JPS59187778A/ja active Granted
Non-Patent Citations (1)
| Title |
|---|
| EUROPEAR JOURNAL OF BIAHEMISTRY=1981 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60152502A (ja) * | 1983-12-17 | 1985-08-10 | コンゾルテイウム・フユール・エレクトロケミツシエ・インヅストリー・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | β‐シクロデキストリンの水溶性エーテルおよびその製法 |
| WO2017195888A1 (ja) * | 2016-05-12 | 2017-11-16 | 国立大学法人 東京大学 | 固体培地での微生物の増殖能を増強する方法 |
| JPWO2017195888A1 (ja) * | 2016-05-12 | 2019-02-07 | 国立大学法人 東京大学 | 固体培地での微生物の増殖能を増強する方法 |
| JP2021090403A (ja) * | 2019-12-12 | 2021-06-17 | 栄研化学株式会社 | レジオネラ属菌培養用の透明培地 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6144470B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1986-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR900007658B1 (ko) | 백일해균 예방항원을 함유하는 ha 유분(留分)과 백일해 왁진의 제조방법 | |
| Imaizumi et al. | Heptakis (2, 6-O-dimethyl) beta-cyclodextrin: a novel growth stimulant for Bordetella pertussis phase I | |
| US4965205A (en) | Culture medium for bacteria of the bordetella genus containing etherified derivative of D-glucose and a cyclodextrin | |
| US4500639A (en) | Culturing Bordetella in media containing etherified cyclodextrin | |
| US5405759A (en) | Heparitinase, process for producing the same and bacteria producing the same | |
| JPH05219942A (ja) | 細菌クロストリジウム・ヒストリチカムの変異株、その製造法及びその用途 | |
| JPS59187778A (ja) | 微生物を培養するための培地 | |
| JPS58155085A (ja) | ヒポミクロビウム属微生物及び該微生物を利用する水溶液中のメチル基含有化合物の分解方法 | |
| JPS5867182A (ja) | 培養方法及び培地 | |
| JPS5918989B2 (ja) | 生物学的活性物質の製法 | |
| JPH06233692A (ja) | γ−サイクロデキストリンの増収方法 | |
| JP3250852B2 (ja) | バチルス・メガテリウムの生産する新規サイクロデキストリン・グルカノトランスフェラーゼ、その製造法及び該酵素を用いるサイクロデキストリンの製造法 | |
| JPS64929B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| KR830002250B1 (ko) | 사이클로덱스트린(Cyclodextrine)의 제조법 | |
| US5492829A (en) | Klebsiella oxytoca No. 19-1 capable of producing α-cyclodextrin | |
| JPS60155127A (ja) | 生物学的活性物質の製法 | |
| JP2593147B2 (ja) | 感染防御抗原産生菌用培地組成物 | |
| JP3272416B2 (ja) | 新規サイクロデキストリン・グルカノトランスフェラーゼ、その製造法及び該酵素を用いるサイクロデキストリンの製造法 | |
| JPH0375151B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| JPS6028277B2 (ja) | ボルデテラ属に属する微生物の培養方法及び培地 | |
| KR960014622B1 (ko) | 폐렴균 배양용 배지 및 폐렴균 협막 다당류 성분의 개선된 제조방법 | |
| JPH0229311B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| JPS59184132A (ja) | 百日ぜきワクチンの製造方法 | |
| JPH0358784A (ja) | 新規なシクロマルトデキストリナーゼ及びその製造方法 | |
| JPH1175827A (ja) | 新規なキトサナーゼ生産菌とキトサナーゼの製造方法 |